Profiling of age-related changes in the tibialis anterior muscle proteome of the mdx mouse model of dystrophinopathy

Journal of Biomedicine and Biotechnology

Volumn 2012, Issue , 2012, Pages

  Carberry, Steven ^a   Zweyer, Margit ^b   Swandulla, Dieter ^b   Ohlendieck, Kay ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARBONATE DEHYDRATASE; DYSTROPHIN; FLAVOPROTEIN; FRUCTOSE BISPHOSPHATE ALDOLASE; HEAT SHOCK PROTEIN 27; MYOSIN; PROTEOME; PYRUVATE KINASE; TROPOMYOSIN; MUSCLE PROTEIN;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DYSTROPHINOPATHY; EXPERIMENTAL MODEL; IMMUNOBLOTTING; MASS SPECTROMETRY; MOUSE; MUSCLE NECROSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEOMICS; TIBIALIS ANTERIOR MUSCLE; TWO DIMENSIONAL GEL ELECTROPHORESIS; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE; AGING; ANIMAL; DUCHENNE MUSCULAR DYSTROPHY; HINDLIMB; METABOLISM;

ANIMALIA; MUS;

AGING; ANIMALS; HINDLIMB; MICE; MICE, INBRED MDX; MUSCLE PROTEINS; MUSCULAR DYSTROPHY, DUCHENNE; PROTEOME;

EID: 84871824209     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2012/691641     Document Type: Article

References (78)

1. Campbell K. P., Three muscular dystrophies: loss of cytoskeleton- extracellular matrix linkage. Cell 1995 80 5 675 679 2-s2.0-0028914964
2. Ohlendieck K., Towards an understanding of the dystrophin-glycoprotein complex: linkage between the extracellular matrix and the membrane cytoskeleton in muscle fibers. European Journal of Cell Biology 1996 69 1 1 10 2-s2.0-0030026119 (Pubitemid 26033923)
3. Michele D. E., Campbell K. P., Dystrophin-glycoprotein complex: post-translational processing and dystroglycan function. Journal of Biological Chemistry 2003 278 18 15457 15460 2-s2.0-0038182574 10.1074/jbc.R200031200 (Pubitemid 36799650)
4. Ervasti J. M., Sonnemann K. J., Biology of the striated muscle dystrophin-glycoprotein complex. International Review of Cytology 2008 265 191 225 2-s2.0-38949130017 10.1016/S0074-7696(07)65005-0 (Pubitemid 351215989)
5. Gumerson J. D., Michele D. E., The dystrophin-glycoprotein complex in the prevention of muscle damage. Journal of Biomedicine and Biotechnology 2011 2011 210797
6. Hoffman E. P., Brown R. H., Kunkel L. M., Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987 51 6 919 928 2-s2.0-0023614188
7. Culligan K. G., Mackey A. J., Finn D. M., Maguire P. B., Ohlendieck K., Role of dystrophin isoforms and associated proteins in muscular dystrophy. International Journal of Molecular Medicine 1998 2 6 639 648 2-s2.0-0032246520
8. Dalkilic I., Kunkel L. M., Muscular dystrophies: genes to pathogenesis. Current Opinion in Genetics and Development 2003 13 3 231 238 2-s2.0-0038054542 10.1016/S0959-437X(03)00048-0 (Pubitemid 36645085)
9. Ohlendieck K., Matsumura K., Ionasescu V. V., Towbin J. A., Bosch E. P., Weinstein S. L., Sernett S. W., Campbell K. P., Duchenne muscular dystrophy: deficiency of dystrophin-associated proteins in the sarcolemma. Neurology 1993 43 4 795 800 2-s2.0-0027481238 (Pubitemid 23121977)
10. Lynch G. S., Rafael J. A., Chamberlain J. S., Faulkner J. A., Contraction-induced injury to single permeabilized muscle fibers from mdx, transgenic mdx, and control mice. American Journal of Physiology 2000 279 4 C1290 C1294 2-s2.0-0033695935
11. Ramaswamy K. S., Palmer M. L., Van Der Meulen J. H., Renoux A., Kostrominova T. Y., Michele D. E., Faulkner J. A., Lateral transmission of force is impaired in skeletal muscles of dystrophic mice and very old rats. Journal of Physiology 2011 589 5 1195 1208 2-s2.0-79951974764 10.1113/jphysiol.2010. 201921
12. Alderton J. M., Steinhardt R. A., Calcium influx through calcium leak channels is responsible for the elevated levels of calcium-dependent proteolysis in dystrophic myotubes. Journal of Biological Chemistry 2000 275 13 9452 9460 2-s2.0-0034737602 10.1074/jbc.275.13.9452 (Pubitemid 30185173)
13. + channels. Proceedings of the National Academy of Sciences of the United States of America 2000 97 9 4950 4955 2-s2.0-0034712587 (Pubitemid 30238663)
14. Culligan K., Banville N., Dowling P., Ohlendieck K., Drastic reduction of calsequestrin-like proteins and impaired calcium binding in dystrophic mdx muscle. Journal of Applied Physiology 2002 92 2 435 445 2-s2.0-0036092560 (Pubitemid 34671005)
15. Dowling P., Doran P., Ohlendieck K., Drastic reduction of sarcalumenin in Dp427 (dystrophin of 427 kDa)-deficient fibres indicates that abnormal calcium handling plays a key role in muscular dystrophy. Biochemical Journal 2004 379 2 479 488 2-s2.0-2342614190 10.1042/BJ20031311 (Pubitemid 38570121)
16. 2+-binding proteins demonstrates decreased calsequestrin expression in dystrophic mouse skeletal muscle. European Journal of Biochemistry 2004 271 19 3943 3952 2-s2.0-4944230808 10.1111/j.1432-1033.2004.04332.x (Pubitemid 39331443)
17. Gehrig S. M., van der Poel C., Sayer T. A., Schertzer J. D., Henstridge D. C., Church J. E., Lamon S., Russell A. P., Davies K. E., Febbraio M. A., Lynch G. S., Hsp72 preserves muscle function and slows progression of severe muscular dystrophy. Nature 2012 484 7394 394 398 10.1038/nature10980
18. Lewis C., Doran P., Ohlendieck K., Proteomic analysis of dystrophic muscle. Methods in Molecular Biology 2012 798 1 357 369 10.1007/978-1-61779-343- 1-20
19. de Hoog C. L., Mann M., Proteomics. Annual Review of Genomics and Human Genetics 2004 5 267 293 2-s2.0-5444223979 10.1146/annurev.genom.4.070802.110305 (Pubitemid 39362748)
20. Cravatt B. F., Simon G. M., Yates J. R., The biological impact of mass-spectrometry-based proteomics. Nature 2007 450 7172 991 1000 2-s2.0-37249014081 10.1038/nature06525 (Pubitemid 350273629)
21. Walther T. C., Mann M., Mass spectrometry-based proteomics in cell biology. Journal of Cell Biology 2010 190 4 491 500 2-s2.0-77955876447 10.1083/jcb.201004052
22. Isfort R. J., Proteomic analysis of striated muscle. Journal of Chromatography B 2002 771 1-2 155 165 2-s2.0-0037023852 10.1016/S1570-0232(02) 00056-9 (Pubitemid 34457726)
23. Ohlendieck K., Skeletal muscle proteomics: current approaches, technical challenges and emerging techniques. Skeletal Muscle 2011 1 1 6 10.1186/2044-5040-1-6
24. Gelfi C., Vasso M., Cerretelli P., Diversity of human skeletal muscle in health and disease: contribution of proteomics. Journal of Proteomics 2011 74 6 774 795 2-s2.0-79955477252 10.1016/j.jprot.2011.02.028
25. Ohlendieck K., Proteomics of skeletal muscle differentiation, neuromuscular disorders and fiber aging. Expert Review of Proteomics 2010 7 2 283 296 2-s2.0-77950795909 10.1586/epr.10.2
26. Ohlendieck K., Proteomic profiling of fast-to-slow muscle transitions during aging. Frontiers in Physiology 2011 2 1 105
27. Aebersold R., Mann M., Mass spectrometry-based proteomics. Nature 2003 422 6928 198 207 2-s2.0-0037435030 10.1038/nature01511 (Pubitemid 36362757)
28. Cañas Montalvo B., López-Ferrer D., Ramos-Fernández A., Camafeita E., Calvo E., Mass spectrometry technologies for proteomics. Briefings in Functional Genomics and Proteomics 2006 4 4 295 320 2-s2.0-33645558990 10.1093/bfgp/eli002
29. Yates J. R., Ruse C. I., Nakorchevsky A., Proteomics by mass spectrometry: approaches, advances, and applications. Annual Review of Biomedical Engineering 2009 11 49 79 2-s2.0-67651173106 10.1146/annurev-bioeng- 061008-124934
30. Lewis C., Carberry S., Ohlendieck K., Proteomic profiling of x-linked muscular dystrophy. Journal of Muscle Research and Cell Motility 2009 30 7-8 267 279 2-s2.0-77951023119 10.1007/s10974-009-9197-6
31. Griffin J. L., Rosiers C. D., Applications of metabolomics and proteomics to the mdx mouse model of Duchenne muscular dystrophy: lessons from downstream of the transcriptome. Genome Medicine 2009 1 3, article 32 2-s2.0-77950830178 10.1186/gm32
32. Alagaratnam S., Mertens B. J. A., Dalebout J. C., Deelder A. M., Van Ommen G. J. B., Den Dunnen J. T., 'T Hoen P. A. C., Serum protein profiling in mice: identification of factor XIIIa as a potential biomarker for muscular dystrophy. Proteomics 2008 8 8 1552 1563 2-s2.0-42549137898 10.1002/pmic. 200700857 (Pubitemid 351580202)
33. Colussi C., Banfi C., Brioschi M., Tremoli E., Straino S., Spallotta F., Mai A., Rotili D., Capogrossi M. C., Gaetano C., Proteomic profile of differentially expressed plasma proteins from dystrophic mice and following suberoylanilide hydroxamic acid treatment. Proteomics 2010 4 1 71 83 2-s2.0-77951727320 10.1002/prca.200900116
34. Gulston M. K., Rubtsov D. V., Atherton H. J., Clarke K., Davies K. E., Lilley K. S., Griffin J. L., A combined metabolomic and proteomic investigation of the effects of a failure to express dystrophin in the mouse heart. Journal of Proteome Research 2008 7 5 2069 2077 2-s2.0-52049098971 10.1021/pr800070p
35. Lewis C., Jockusch H., Ohlendieck K., Proteomic profiling of the dystrophin-deficient MDX heart reveals drastically altered levels of key metabolic and contractile proteins. Journal of Biomedicine and Biotechnology 2010 2010 2-s2.0-77953491510 10.1155/2010/648501 648501
36. Ge Y., Molloy M. P., Chamberlain J. S., Andrews P. C., Proteomic analysis of mdx skeletal muscle: great reduction of adenylate kinase 1 expression and enzymatic activity. Proteomics 2003 3 10 1895 1903 2-s2.0-0142182391 10.1002/pmic.200300561 (Pubitemid 37305883)
37. Ge Y., Molloy M. P., Chamberlain J. S., Andrews P. C., Differential expression of the skeletal muscle proteome in mdx mice at different ages. Electrophoresis 2004 25 15 2576 2585 2-s2.0-4444267191 10.1002/elps.200406013 (Pubitemid 39193668)
38. Gardan-Salmon D., Dixon J. M., Lonergan S. M., Selsby J. T., Proteomic assessment of the acute phase of dystrophin deficiency in mdx mice. European Journal of Applied Physiology 2011 111 11 2763 2773 10.1007/s00421-011-1906-3
39. Doran P., Dowling P., Donoghue P., Buffini M., Ohlendieck K., Reduced expression of regucalcin in young and aged mdx diaphragm indicates abnormal cytosolic calcium handling in dystrophin-deficient muscle. Biochimica et Biophysica Acta 2006 1764 4 773 785 2-s2.0-33646102225 10.1016/j.bbapap.2006.01. 007
40. Doran P., Martin G., Dowling P., Jockusch H., Ohlendieck K., Proteome analysis of the dystrophin-deficient MDX diaphragm reveals a drastic increase in the heat shock protein cvHSP. Proteomics 2006 6 16 4610 4621 2-s2.0-33748339008 10.1002/pmic.200600082 (Pubitemid 44336975)
41. Doran P., Wilton S. D., Fletcher S., Ohlendieck K., Proteomic profiling of antisense-induced exon skipping reveals reversal of pathobiochemical abnormalities in dystrophic mdx diaphragm. Proteomics 2009 9 3 671 685 2-s2.0-60549096114 10.1002/pmic.200800441
42. Lewis C., Ohlendieck K., Proteomic profiling of naturally protected extraocular muscles from the dystrophin-deficient mdx mouse. Biochemical and Biophysical Research Communications 2010 396 4 1024 1029 2-s2.0-77953292369 10.1016/j.bbrc.2010.05.052
43. Carberry S., Zweyer M., Swandulla D., Ohlendieck K., Proteomic profiling of diaphragm muscle during aging of the mdx model of Duchenne muscular dystrophy. International Journal of Molecular Medicine 2012 30 2 229 234
44. Guevel L., Lavoie J. R., Perez-Iratxeta C., Rouger K., Dubreil L., Feron M., Talon S., Brand M., Megeney L. A., Quantitative proteomic analysis of dystrophic dog muscle. Journal of Proteome Research 2011 10 5 2465 2478 2-s2.0-79955865787 10.1021/pr2001385
45. Mesin L., Merlo E., Merletti R., Orizio C., Investigation of motor unit recruitment during stimulated contractions of Tibialis anterior muscle. Journal of Electromyography and Kinesiology 2010 20 4 580 589 2-s2.0-77952958711 10.1016/j.jelekin.2009.11.008
46. Jones D. A., Turner D. L., McIntyre D. B., Newham D. J., Energy turnover in relation to slowing of contractile properties during fatiguing contractions of the human anterior tibialis muscle. Journal of Physiology 2009 587 17 4329 4338 2-s2.0-69949092754 10.1113/jphysiol.2009.175265
47. Gilbert R., Dudley R. W. R., Liu A. B., Petrof B. J., Nalbantoglu J., Karpati G., Prolonged dystrophin expression and functional correction of mdx mouse muscle following gene transfer with a helper-dependent (gutted) adenovirus-encoding murine dystrophin. Human Molecular Genetics 2003 12 11 1287 1299 2-s2.0-0038344798 10.1093/hmg/ddg141 (Pubitemid 36722609)
48. Westermeier R., Marouga R., Protein detection methods in proteomics research. Bioscience Reports 2005 25 1-2 19 32 2-s2.0-26444574929 10.1007/s10540-005-2845-1 (Pubitemid 41437707)
49. Aude-Garcia C., Collin-Faure V., Luche S., Rabilloud T., Improvements and simplifications in in-gel fluorescent detection of proteins using ruthenium II tris-(bathophenanthroline disulfonate): the poor man's fluorescent detection method. Proteomics 2011 11 2 324 328 2-s2.0-78650788773 10.1002/pmic.201000370
50. Durbeej M., Campbell K. P., Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models. Current Opinion in Genetics and Development 2002 12 3 349 361 2-s2.0-0036591684 10.1016/S0959-437X(02)00309-X (Pubitemid 34669835)
51. Bulfield G., Siller W. G., Wight P. A. L., Moore K. J., X chromosome-linked muscular dystrophy (mdx) in the mouse. Proceedings of the National Academy of Sciences of the United States of America 1984 81 4 1189 1192 2-s2.0-0345731966 (Pubitemid 14171480)
52. Sicinski P., Geng Y., Ryder-Cook A. S., Barnard E. A., Darlison M. G., Barnard P. J., The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 1989 244 4912 1578 1580 2-s2.0-0024353559 (Pubitemid 19189735)
53. Ohlendieck K., Campbell K. P., Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice. Journal of Cell Biology 1991 115 6 1685 1694 2-s2.0-0026328022 (Pubitemid 21910008)
54. Irintchev A., Zweyer M., Wernig A., Impaired functional and structural recovery after muscle injury in dystrophic mdx mice. Neuromuscular Disorders 1997 7 2 117 125 2-s2.0-0030936938 10.1016/S0960-8966(96)00422-1 (Pubitemid 27168713)
55. Staunton L., Jockusch H., Wiegand C., Albrecht T., Ohlendieck K., Identification of secondary effects of hyperexcitability by proteomic profiling of myotonic mouse muscle. Molecular BioSystems 2011 7 8 2480 2489 2-s2.0-79960356845 10.1039/c1mb05043e
56. Rabilloud T., Strub J. M., Luche S., Van Dorsselaer A., Lunardi J., A comparison between Sypro Ruby and ruthenium ii tris (bathophenanthroline disulfonate) as fluorescent stains for protein detection in gels. Proteomics 2001 1 5 699 704 2-s2.0-0035346790 (Pubitemid 33588320)
57. Gannon J., Staunton L., O'Connell K., Doran P., Ohlendieck K., Phosphoproteomic analysis of aged skeletal muscle. International Journal of Molecular Medicine 2008 22 1 33 42 2-s2.0-51249091494
58. Emery A. E. H., The muscular dystrophies. The Lancet 2002 359 9307 687 695 2-s2.0-0037160782 10.1016/S0140-6736(02)07815-7 (Pubitemid 34203773)
59. Spurney C. F., Gordish-Dressman H., Guerron A. D., Sali A., Pandey G. S., Rawat R., Van Der Meulen J. H., Cha H. J., Pistilli E. E., Partridge T. A., Hoffman E. P., Nagaraju K., Preclinical drug trials in the mdx mouse: assessment of reliable and sensitive outcome measures. Muscle and Nerve 2009 39 5 591 602 2-s2.0-65949114863 10.1002/mus.21211
60. Partridge T. A., Impending therapies for Duchenne muscular dystrophy. Current Opinion in Neurology 2011 24 5 415 422 10.1097/WCO.0b013e32834aa3f1
61. Lefaucheur J. P., Pastoret C., Sebille A., Phenotype of dystrophinopathy in old mdx mice. Anatomical Record 1995 242 1 70 76 2-s2.0-0029001953
62. Wieneinger M. A., Ted Abresch R., Walsh S. A., Carter G. T., Effects of aging and voluntary exercise on the function of dystrophic muscle from mdx mice. American Journal of Physical Medicine and Rehabilitation 1998 77 1 20 27 2-s2.0-0344043503 10.1097/00002060-199801000-00004 (Pubitemid 28113366)
63. Pastoret C., Sebille A., Age-related differences in regeneration of dystrophic (mdx) and normal muscle in the mouse. Muscle and Nerve 1995 18 10 1147 1154 2-s2.0-0029124967 10.1002/mus.880181011
64. Pastoret C., Sebille A., mdx mice show progressive weakness and muscle deterioration with age. Journal of the Neurological Sciences 1995 129 2 97 105 2-s2.0-0028906307 10.1016/0022-510X(94)00276-T
65. Lynch G. S., Hinkle R. T., Chamberlain J. S., Brooks S. V., Faulkner J. A., Force and power output of fast and slow skeletal muscles from mdx mice 6-28 months old. Journal of Physiology 2001 535 2 591 600 2-s2.0-0035449110 10.1111/j.1469-7793.2001.00591.x (Pubitemid 32825693)
66. 2+ homeostasis during fatigue. Experimental Physiology 2010 95 5 641 656 2-s2.0-77951160191 10.1113/expphysiol.2009.052019
67. Chamberlain J. S., Metzger J., Reyes M., Townsend D., Faulkner J. A., Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma. Federation of American Societies for Experimental Biology Journal 2007 21 9 2195 2204 2-s2.0-34347374860 10.1096/fj.06-7353com (Pubitemid 47026454)
68. Mouisel E., Vignaud A., Hourdé C., Butler-Browne G., Ferry A., Muscle weakness and atrophy are associated with decreased regenerative capacity and changes in mtor signaling in skeletal muscles of venerable (18-24-month-old) dystrophic mdx mice. Muscle and Nerve 2010 41 6 809 818 2-s2.0-77953042829 10.1002/mus.21624
69. Fremont P., Charest P. M., Cote C., Rogers P. A., Carbonic anhydrase III in skeletal muscle fibers: an immunocytochemical and biochemical study. Journal of Histochemistry and Cytochemistry 1988 36 7 775 782 2-s2.0-0023899059
70. Geers C., Gros G., Carbon dioxide transport and carbonic anhydrase in blood and muscle. Physiological Reviews 2000 80 2 681 715 2-s2.0-0034100924 (Pubitemid 30164947)
71. Brownson C., Isenberg H., Brown W., Salmons S., Edwards Y., Changes in skeletal muscle gene transcription induced by chronic stimulation. Muscle and Nerve 1988 11 11 1183 1189 2-s2.0-0023743168 (Pubitemid 18263157)
72. Brownson C., Loughna P. T., Alterations in the mRNA levels of two metabolic enzymes in rat skeletal muscle during stretch-induced hypertrophy and disuse atrophy. Pflugers Archiv European Journal of Physiology 1996 431 6 990 992 2-s2.0-0029863042 10.1007/s004240050097 (Pubitemid 26134716)
73. Côté C. H., Ambrosio F., Perreault G., Metabolic and contractile influence of carbonic anhydrase III in skeletal muscle is age dependent. American Journal of Physiology 1999 276 2 R559 R565 2-s2.0-17144469104 (Pubitemid 29098693)
74. Staunton L., Zweyer M., Swandulla D., Ohlendieck K., Mass spectrometry-based proteomic analysis of middle-aged versus aged vastus lateralis reveals increased levels of carbonic anhydrase isoform 3 in senescent human skeletal muscle. International Journal of Molecular Medicine. In press 10.3892/ijmm.2012.1056
75. Toogood H. S., Leys D., Scrutton N. S., Dynamics driving function-new insights from electron transferring flavoproteins and partner complexes. Federation of European Biochemical Societies Journal 2007 274 21 5481 5504 2-s2.0-35448974949 10.1111/j.1742-4658.2007.06107.x (Pubitemid 47622089)
76. Ohlendieck K., Proteomics of skeletal muscle glycolysis. Biochimica et Biophysica Acta 2010 1804 11 2089 2101 2-s2.0-77956650310 10.1016/j.bbapap.2010. 08.001
77. Doran P., O'Connell K., Gannon J., Kavanagh M., Ohlendieck K., Opposite pathobiochemical fate of pyruvate kinase and adenylate kinase in aged rat skeletal muscle as revealed by proteomic DIGE analysis. Proteomics 2008 8 2 364 377 2-s2.0-38949107303 10.1002/pmic.200700475 (Pubitemid 351212333)
78. Doran P., Donoghue P., O'Connell K., Gannon J., Ohlendieck K., Proteomics of skeletal muscle aging. Proteomics 2009 9 4 989 1003 2-s2.0-61549123010 10.1002/pmic.200800365